
David A. Saunders
Examiner (ID: 251)
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644, 1621, 1802, 1816, 1801, 1208, 2899, 1633 |
| Total Applications | 1367 |
| Issued Applications | 898 |
| Pending Applications | 119 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5631528
[patent_doc_number] => 20060147998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Method for diagnosing and monitoring critically ill patients'
[patent_app_type] => utility
[patent_app_number] => 11/290722
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4549
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147998.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290722
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290722 | Method for diagnosing and monitoring critically ill patients | Nov 29, 2005 | Abandoned |
Array
(
[id] => 5694160
[patent_doc_number] => 20060154307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Receptor assay'
[patent_app_type] => utility
[patent_app_number] => 11/290796
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11218
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154307.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290796 | Receptor assay | Nov 28, 2005 | Abandoned |
Array
(
[id] => 411679
[patent_doc_number] => 07282481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-16
[patent_title] => 'Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same'
[patent_app_type] => utility
[patent_app_number] => 11/285798
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7700
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/282/07282481.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285798 | Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same | Nov 22, 2005 | Issued |
Array
(
[id] => 5580906
[patent_doc_number] => 20090176252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Method for the Measurement of Endocrine Substances In an Analyte'
[patent_app_type] => utility
[patent_app_number] => 11/988063
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9046
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176252.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988063
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988063 | Method for the measurement of endocrine substances in an analyte | Nov 21, 2005 | Issued |
Array
(
[id] => 5799303
[patent_doc_number] => 20060034836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Enhancing the circulating half-life of antibody-based fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 11/268191
[patent_app_country] => US
[patent_app_date] => 2005-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11487
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034836.pdf
[firstpage_image] =>[orig_patent_app_number] => 11268191
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/268191 | Enhancing the circulating half-life of antibody-based fusion proteins | Nov 6, 2005 | Issued |
Array
(
[id] => 5705232
[patent_doc_number] => 20060194280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Methods for refolding of recombinant antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/255528
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 33836
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194280.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255528
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255528 | Methods for refolding of recombinant antibodies | Oct 20, 2005 | Issued |
Array
(
[id] => 5016244
[patent_doc_number] => 20070259453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Method of Antibody Purification'
[patent_app_type] => utility
[patent_app_number] => 11/577203
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11081
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577203
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577203 | Method of antibody purification | Oct 20, 2005 | Issued |
Array
(
[id] => 4664437
[patent_doc_number] => 20080255344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Immuno-Adsorbers For Treatment of Inflammations'
[patent_app_type] => utility
[patent_app_number] => 11/665945
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1918
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255344.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665945
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665945 | Immuno-Adsorbers For Treatment of Inflammations | Oct 6, 2005 | Abandoned |
Array
(
[id] => 504002
[patent_doc_number] => 07202043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-10
[patent_title] => 'Detecting cell membrane protein endocytosis'
[patent_app_type] => utility
[patent_app_number] => 11/244256
[patent_app_country] => US
[patent_app_date] => 2005-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7624
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/202/07202043.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244256
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244256 | Detecting cell membrane protein endocytosis | Oct 3, 2005 | Issued |
Array
(
[id] => 5819980
[patent_doc_number] => 20060024293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Human antibodies that bind human TNFalpha'
[patent_app_type] => utility
[patent_app_number] => 11/233252
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20794
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024293.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233252
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233252 | Human antibodies that bind human TNFα | Sep 20, 2005 | Issued |
Array
(
[id] => 5636912
[patent_doc_number] => 20060067885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Method and kit for imaging and treating organs and tissues'
[patent_app_type] => utility
[patent_app_number] => 11/229872
[patent_app_country] => US
[patent_app_date] => 2005-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7506
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20060067885.pdf
[firstpage_image] =>[orig_patent_app_number] => 11229872
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/229872 | Method of affecting a function of or ablating a non-malignant cell | Sep 19, 2005 | Issued |
Array
(
[id] => 795467
[patent_doc_number] => 07429381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-30
[patent_title] => 'Production and use of novel peptide-based agents for use with bi-specific antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/216033
[patent_app_country] => US
[patent_app_date] => 2005-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16159
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/429/07429381.pdf
[firstpage_image] =>[orig_patent_app_number] => 11216033
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/216033 | Production and use of novel peptide-based agents for use with bi-specific antibodies | Aug 31, 2005 | Issued |
Array
(
[id] => 4760199
[patent_doc_number] => 20080312425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Ion Exchange Chromatography and Purification of Antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/595671
[patent_app_country] => US
[patent_app_date] => 2005-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16359
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595671
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595671 | Ion Exchange Chromatography and Purification of Antibodies | Aug 29, 2005 | Abandoned |
Array
(
[id] => 6977883
[patent_doc_number] => 20050287601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Diagnostics and therapeutics for macular degeneration-related disorders'
[patent_app_type] => utility
[patent_app_number] => 11/205370
[patent_app_country] => US
[patent_app_date] => 2005-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14216
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287601.pdf
[firstpage_image] =>[orig_patent_app_number] => 11205370
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/205370 | Diagnostics and therapeutics for macular degeneration-related disorders | Aug 15, 2005 | Issued |
Array
(
[id] => 273946
[patent_doc_number] => 07560110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-14
[patent_title] => 'Production and use of novel peptide-based agents with bispecific antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/198846
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 41615
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560110.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198846
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198846 | Production and use of novel peptide-based agents with bispecific antibodies | Aug 7, 2005 | Issued |
Array
(
[id] => 5648371
[patent_doc_number] => 20060134103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands'
[patent_app_type] => utility
[patent_app_number] => 11/191244
[patent_app_country] => US
[patent_app_date] => 2005-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 63123
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134103.pdf
[firstpage_image] =>[orig_patent_app_number] => 11191244
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/191244 | Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands | Jul 26, 2005 | Abandoned |
Array
(
[id] => 5715582
[patent_doc_number] => 20060078945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Complex formed by N-linked glycoproteins (SIBLINGS) and Factor H'
[patent_app_type] => utility
[patent_app_number] => 11/185924
[patent_app_country] => US
[patent_app_date] => 2005-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22925
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078945.pdf
[firstpage_image] =>[orig_patent_app_number] => 11185924
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/185924 | Complex formed by N-linked glycoproteins (SIBLINGS) and Factor H | Jul 18, 2005 | Abandoned |
Array
(
[id] => 5636911
[patent_doc_number] => 20060067884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Method for radiolabeling antibodies with yttrium-90'
[patent_app_type] => utility
[patent_app_number] => 11/181811
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10906
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20060067884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181811
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181811 | Method for radiolabeling antibodies with yttrium-90 | Jul 14, 2005 | Issued |
Array
(
[id] => 5165609
[patent_doc_number] => 20070287196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'Enzymatic Modification of Cell-Surface H Antigen by Glycosyltransferases'
[patent_app_type] => utility
[patent_app_number] => 11/628860
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7211
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20070287196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11628860
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/628860 | Enzymatic Modification of Cell-Surface H Antigen by Glycosyltransferases | Jun 9, 2005 | Abandoned |
Array
(
[id] => 5601794
[patent_doc_number] => 20060292139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Fusion proteins for prodrug activation'
[patent_app_type] => utility
[patent_app_number] => 11/135155
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7166
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292139.pdf
[firstpage_image] =>[orig_patent_app_number] => 11135155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/135155 | Fusion proteins for prodrug activation | May 22, 2005 | Issued |